📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method. (2023)

First Author: Cherlin S

Attributed to: Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/biostatistics/kxaa055

PubMed Identifier: 34165151

Publication URI: http://europepmc.org/abstract/MED/34165151

Type: Journal Article/Review

Volume: 24

Parent Publication: Biostatistics (Oxford, England)

Issue: 2

ISSN: 1465-4644